Skip to main content
All lobbying filings

FOLEY HOAG LLP

FOLEY HOAG LLP filed a Q2 report for TONIX PHARMACEUTICALS on July 17, 2026, reporting $50,000 in lobbying income.

Lobbying for TONIX PHARMACEUTICALS · Manufacturer of pharmaceutical products.

All filings by FOLEY HOAG LLP · Everything TONIX PHARMACEUTICALS has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New York

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues pertaining to access to non-opioid alternatives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem